Motola D.; Poluzzi E.; Marra A.; Biagi C.; Piccinni C.; Montanaro N., Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone, in: ABSTRACTS, Chichester, Wiley Blackewell, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2010, 19, pp. 129 - 129 (atti di: 26th ICPE: International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, England, UK, August 19-22, 2010) [atti di convegno-abstract]
Piccinni C; Sacripanti C; Poluzzi E; Motola D; Magro L; Moretti U; Conforti A; Montanaro N., Stronger association of drug-induced progressive multifocal
leukoencephalopathy (PML) with biological immunomodulating agents., «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2010, 66, pp. 199 - 206 [articolo]
E. Raschi; E. Poluzzi; U. Moretti; F. De Ponti, TdP liability of fluoroquinolones: integrated approach based on the FDA spontaneous reports and literature data., in: Supplement: Abstracts from the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Rhode Island Convention Center, Providence, Rhode Island, USA. August 16–19, 2009, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2010, 19, pp. S1 - S347 (atti di: 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, August 17-22) [atti di convegno-abstract]
Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C.; Vaccheri A.; Montanaro N., A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital., in: Abstracts of the 9th Congress of the European Association for Clinical Pharmacology and Therapeutics, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2009, 105 (S1), pp. 139 - 140 (atti di: 9th Congress of the European Association for Clinical Pharmacology and Therapeutics, Edinburgh, UK, 12-15 July, 2009) [atti di convegno-abstract]
E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti, Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System., «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2009, 105, pp. 31 - 31 [articolo]
Poluzzi E; Raschi E; Moretti U; De Ponti F., Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)., «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2009, 18, pp. 512 - 518 [articolo]
Raschi E; Poluzzi E; Zuliani C; Muller A; Goossens H; De Ponti F., Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period., «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2009, 67, pp. 88 - 98 [articolo]
Piccinni C.; Sacripanti C.; Poluzzi E.; Motola D.; Magro L.; Moretti U.; Conforti A.; Montanaro N., Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction?, in: ABSTRACTS ONLINE, Rimini, Società Italiana di Farmacologia, 2009, pp. 299 - 299 (atti di: 34° Congresso Nazionale della Società Italiana di Farmacologia, Rimini, Italia, 14-17 Ottobre 2009.) [atti di convegno-abstract]
Piccinni C.; Sacripanti C.; Poluzzi E.; Motola D.; Magro L.; Moretti U.; Montanaro N., Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction?, in: ABSTRACTS, Oxford, Wiley B, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2009, 105 Suppl 1, pp. 88 - 88 (atti di: 9th Congress of the EACPT (European Association for Clinical Pharmacology and Therapeutics), Edinburgh, July 12-15, 2009) [atti di convegno-abstract]
Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N., A 3 year survey on the use of antibacterial agents in five Italian hospitals., «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2008, 61, pp. 953 - 958 [articolo]
Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N., Adherence to statin therapy and patients' cardiovascular risk: a
pharmacoepidemiological study in Italy, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2008, 64, pp. 425 - 432 [articolo]
M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vaccheri; N. Montanaro., Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital., in: Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2008, 17, pp. S223 - S223 (atti di: 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Copenhagen, Denmark, 17-20 August, 2008) [atti di convegno-abstract]
Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G., Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy., «JOURNAL OF HYPERTENSION», 2008, 26, pp. 819 - 824 [articolo]
E. Poluzzi; E. Raschi; C. Zuliani; A. Muller; H. Goossens; F. De Ponti, Exposure to antibacterials with QT-liability in 15 European countries: trends over a 7-year period., in: Supplement: Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Copenhagen, Denmark, August 17–20, 2008., «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2008, 17, pp. S1 - S294. (atti di: 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Copenaghen, August 17-20) [atti di convegno-abstract]
Piccinni C.; Sacripanti C.; Poluzzi E.; Motola D.; Magro L.; Moretti U.; Montanaro N., Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci?, in: RIASSUNTI, ROMA, ISTISAN Congressi, «ISTISAN CONGRESSI», 2008, 08/C13, pp. 77 - 77 (atti di: XVII Seminario Nazionale. La valutazione dell'uso e della sicurezza dei farmaci: esperienze in Italia, Istituto Superiore di Sanità, Roma, 15 dicembre 2008) [atti di convegno-abstract]
